Sofwave to Participate in the Wells Fargo 21st Annual Healthcare Conference

SAN CLEMENTE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference on September 8-10, 2026.

About Sofwave Medical
Sofwave Medical Ltd. (TASE: SOFW) is a global regenerative aesthetics company advancing non-invasive technologies for skin and body. Its proprietary SUPERB™ (Synchronous Ultrasound Parallel Beam) technology delivers controlled ultrasound energy to the mid-dermis to stimulate the body’s natural regenerative response and is FDA-cleared for the treatment of facial lines and wrinkles, lifting the eyebrow and lax submental and neck tissue, improving the appearance of skin laxity on the upper arms, short-term improvement in the appearance of cellulite, and treatment of acne scars.

Sofwave’s portfolio also includes Pure Impact™, which utilizes electrical muscle stimulation (EMS) technology for muscle strengthening, toning and firming. Together, Sofwave’s technologies provide physicians with clinically supported, non-invasive solutions for the evolving needs of aesthetic patients worldwide. Contact: [email protected]

Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
(212) 915-2578
[email protected]

You May Also Be Interested In

• Pemi Launches a New Women's Daily Supplement Routine Built Specifically for Perimenopause
• Epic Gold Announces a Non-Brokered Private Placement
• Alexander Dennis secures new £57m Liverpool City Region order to expand customer fleet to 400 vehicles